Exhibition Review丨Dr.Yijun Shen reveals 3D immobilised culture and high-throughput purification technology at T20 Conference

It is worth mentioning that on the morning of July 13th, the sub forum on high-quality production and application of extracellular vesicles was grandly launched, becoming a major highlight of this conference. Dr. Shen Yijun, Vice President of Technology Development at Tongteng New Creation, delivered a unique keynote speech titled "Application of 3D Fixed Cultivation and High throughput Purification Technology in Large scale Extracellular Secretion Production".

In recent years, extracellular vesicles have shone in cutting-edge fields such as diagnosis and detection, disease treatment, precise drug delivery, and regenerative medicine due to their unique low immunogenicity, excellent stability, low toxicity, and critical role in intercellular communication. They have rapidly risen to become a popular track in scientific research and industry. Especially extracellular vesicles derived from mesenchymal stem cells are a favorite in clinical research. The significant increase in secretion and therapeutic activity of extracellular vesicles demonstrated through 3D culture has injected new vitality into global medical innovation.

However, how to achieve large-scale application of 3D cultivation technology, optimize cost control, and support efficient high-throughput purification methods while ensuring quality remains a major challenge in the industry. Against this backdrop, Tongteng Xinchuang (Suzhou) Technology Co., Ltd., with its profound technological accumulation and innovation capabilities, has launched CEL-G® A comprehensive solution for one-stop production of extracellular vesicles. This solution integrates serum-free culture medium, advanced fixed bed reactor, and automated extracellular vesicle concentration and purification equipment. It not only achieves 3D efficient cultivation of mesenchymal stem cells and continuous extracellular vesicle harvesting, but also opens up a new path for the large-scale and standardized production of extracellular vesicles.

In Dr. Shen's speech, he also delved into the use of CEL-G® The series of products successfully implemented the 3D culture of mesenchymal stem cells and efficiently harvested exosomes, which fully demonstrated the technical progressiveness and market application potential of the program, and brought profound inspiration and infinite imagination to the participants.

Overall, CEL-G® A one-stop solution for extracellular vesicle production has successfully overcome the challenges of large-scale extracellular vesicle production! We look forward to CEL-G® The series of products will achieve better performance in the future market, promote progress in the field of extracellular vesicles in China, and provide customers with better and more efficient services. In addition, we also hope that Tengxinchuang can continue to make breakthroughs in technological innovation, bringing more breakthroughs and surprises to China's biotechnology field.